Andrew F Inglis, | |
4800 Sand Point Way Ne, Seattle, WA 98105-3901 | |
(206) 987-2000 | |
Not Available |
Full Name | Andrew F Inglis |
---|---|
Gender | Male |
Speciality | Otolaryngology - Pediatric Otolaryngology |
Location | 4800 Sand Point Way Ne, Seattle, Washington |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255421145 | NPI | - | NPPES |
6113 | Other | INTERNAL ID-MOTOR VEHICLE ID | |
1028695 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD00019970 (Washington) | Secondary |
207YP0228X | Otolaryngology - Pediatric Otolaryngology | MD00019970 (Washington) | Primary |
Entity Name | The Association Of Chrmc And University Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1255449963 PECOS PAC ID: 9133032964 Enrollment ID: O20031107000585 |
News Archive
Orthovita, Inc., an orthobiologics and biosurgery company, reported financial results for the quarter ended June 30, 2010. Product sales for the second quarter of 2010 were $23.9 million compared to $24.5 million for the second quarter of 2009. Product sales for the second quarter of 2009 included $0.6 million from the sale of Vitomatrix™, a bone graft material used in dental products. There were no Vitomatrix sales in the second quarter of 2010 and no further sales of Vitomatrix are currently expected.
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-125(AZD4076), by its collaboration partner AstraZeneca.
Hapten Sciences Inc. of Memphis, Tenn., has licensed a compound developed by ElSohly Laboratories Inc. and University of Mississippi pharmaceutical researchers to prevent reactions to poison ivy, oak and sumac.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Andrew F Inglis, 4500 Sand Point Way Ne, #100, Seattle, WA 98105-3900 Ph: () - | Andrew F Inglis, 4800 Sand Point Way Ne, Seattle, WA 98105-3901 Ph: (206) 987-2000 |
News Archive
Orthovita, Inc., an orthobiologics and biosurgery company, reported financial results for the quarter ended June 30, 2010. Product sales for the second quarter of 2010 were $23.9 million compared to $24.5 million for the second quarter of 2009. Product sales for the second quarter of 2009 included $0.6 million from the sale of Vitomatrix™, a bone graft material used in dental products. There were no Vitomatrix sales in the second quarter of 2010 and no further sales of Vitomatrix are currently expected.
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today that dosing has begun in a first-in-human Phase I clinical study of RG-125(AZD4076), by its collaboration partner AstraZeneca.
Hapten Sciences Inc. of Memphis, Tenn., has licensed a compound developed by ElSohly Laboratories Inc. and University of Mississippi pharmaceutical researchers to prevent reactions to poison ivy, oak and sumac.
› Verified 3 days ago
Judith A White, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1600 E Jefferson St, Suite 205, Seattle, WA 98122 Phone: 206-320-3900 Fax: 206-320-3899 | |
Kathleen Makielski, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 904 7th Ave, Seattle, WA 98104 Phone: 206-329-1760 | |
David Louis Horn, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 4800 Sand Point Way Ne, Mailstop W-7729, Seattle, WA 98105 Phone: 206-987-2105 Fax: 206-987-3878 | |
Amit D Bhrany, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Bb1165, Box 356515, Seattle, WA 98195 Phone: 206-543-5230 Fax: 206-543-5152 | |
Gabriela Sanchez, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Broadway Ste 200, Seattle, WA 98122 Phone: 206-215-6009 Fax: 206-215-1771 | |
Sapna Ashok Patel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 600 Broadway Ste 280, Seattle, WA 98122 Phone: 206-386-3550 Fax: 206-386-3550 | |
John P Rowland, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 200 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 |